ANPEP and cancer: In vitro fluorescence microscopy evaluation demonstrated that the peptide was actively taken up by a CD13+ cancer cell, showing minimal binding to CD13− cells, and displayed 3,6-fold greater affinity than a linear form also when conjugated on the liposomal surface of a LSTL [22].